Craig T Jordan

Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.

Rudi Fasan, R. Fasan, C. Jordan, 2014, ACS chemical biology.

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.

Monica L Guzman, M. Carroll, Xiaojie Li, 2008, Blood.

Leukemia stemness signatures step toward the clinic.

Craig T Jordan, Michael W Becker, 2011, Cell stem cell.

Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.

Liping Wei, Monica L Guzman, P. Crooks, 2010, Blood.

A test of homogeneity for age-dependent branching processes with immigration.

Ollivier Hyrien, O. Hyrien, N. Yanev, 2015, Electronic journal of statistics.

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.

Derick R. Peterson, Monica L Guzman, D. Howard, 2005, Blood.

Therapeutic targeting of acute myeloid leukemia stem cells.

D. Pollyea, C. Jordan, Craig T Jordan, 2017, Blood.

Leukemia stem cells and microenvironment: biology and therapeutic targeting.

M. Konopleva, C. Jordan, Craig T Jordan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling.

Fatima Al-Shahrour, Gabriela Alexe, David E Root, 2013, Cancer cell.